Hereditary spastic paraparesis presenting as cerebral palsy due to ADD3 variant with mechanistic insight provided by a Drosophila γ‐adducin model

Cerebral palsy (CP) causes neurological disability in early childhood. Hypoxic‐ischaemic injury plays a major role in its aetiology, nevertheless, genetic and epigenetic factors may contribute to the clinical presentation. Mutations in ADD3 (encoding γ‐adducin) gene have been described in a monogenic form of spastic quadriplegic cerebral palsy (OMIM 601568). We studied a 16‐year‐old male with spastic diplegia. Several investigations including neurometabolic testing, brain and spine magnetic resonance imaging (MRI) and CGH‐Array were normal. Further, clinical genetics assessment and whole exome sequencing (WES) gave the diagnosis. We generated an animal model using Drosophila to study the effects of γ‐adducin loss and gain of function. WES revealed a biallelic variant in the ADD3 gene, NM_016824.5(ADD3): c.1100G > A, p.(Gly367Asp). Mutations in this gene have been described as an ultra‐rare autosomal recessive, which is a known form of inherited cerebral palsy. Molecular modelling suggests that this mutation leads to a loss of structural integrity of γ‐adducin and is therefore expected to result in a decreased level of functional protein. Pan‐neuronal over‐expression or knock‐down of the Drosophila ortholog of ADD3 called hts caused a reduction of life span and impaired locomotion thereby phenocopying aspects of the human disease. Our animal experiments present a starting point to understand the biological processes underpinning the clinical phenotype and pathogenic mechanisms, to gain insights into potential future methods for treating or preventing ADD3 related spastic quadriplegic cerebral palsy.

[1]  J. Gécz,et al.  Targeted resequencing identifies genes with recurrent variation in cerebral palsy , 2019, npj Genomic Medicine.

[2]  S. Stein,et al.  Novel ERCC2 mutation in two siblings with trichothiodystrophy , 2019, Pediatric dermatology.

[3]  R. Kirby,et al.  Cerebral Palsy: Diagnosis, Epidemiology, Genetics, and Clinical Update. , 2019, Advances in pediatrics.

[4]  C. Ross,et al.  Atypical cerebral palsy: genomics analysis enables precision medicine , 2018, Genetics in Medicine.

[5]  H. Smeets,et al.  Whole Exome Sequencing Is the Preferred Strategy to Identify the Genetic Defect in Patients With a Probable or Possible Mitochondrial Cause , 2018, Front. Genet..

[6]  K. Nakayama,et al.  Genomic analysis identifies masqueraders of full‐term cerebral palsy , 2018, Annals of clinical and translational neurology.

[7]  Sarah McIntyre,et al.  Early, Accurate Diagnosis and Early Intervention in Cerebral Palsy: Advances in Diagnosis and Treatment , 2017, JAMA pediatrics.

[8]  J. Gécz,et al.  The genetic basis of cerebral palsy , 2017, Developmental medicine and child neurology.

[9]  Sikandar G. Khan,et al.  GTF2E2 Mutations Destabilize the General Transcription Factor Complex TFIIE in Individuals with DNA Repair-Proficient Trichothiodystrophy. , 2016, American journal of human genetics.

[10]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[11]  R A Gibbs,et al.  Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy , 2015, Molecular Psychiatry.

[12]  M. Johnston,et al.  A Diagnostic Approach for Cerebral Palsy in the Genomic Era , 2014, NeuroMolecular Medicine.

[13]  J. Pathakamuri,et al.  A low-cost method for analyzing seizure-like activity and movement in Drosophila. , 2014, Journal of visualized experiments : JoVE.

[14]  R. Woltjer,et al.  Mutations in Gamma Adducin are Associated With Inherited Cerebral Palsy , 2013, Annals of neurology.

[15]  A. Al-Chalabi,et al.  Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes , 2013, Human molecular genetics.

[16]  J. Wessnitzer,et al.  Open Source Tracking and Analysis of Adult Drosophila Locomotion in Buridan's Paradigm with and without Visual Targets , 2012, PloS one.

[17]  I. Novak,et al.  Cerebral palsy--don't delay. , 2011, Developmental disabilities research reviews.

[18]  Carl T. Wittwer,et al.  uMELT: prediction of high-resolution melting curves and dynamic melting profiles of PCR products in a rich web application , 2011, Bioinform..

[19]  W. Jones,et al.  The expanding reach of the GAL4/UAS system into the behavioral neurobiology of Drosophila. , 2009, BMB reports.

[20]  Dan S. Tawfik,et al.  Stability effects of mutations and protein evolvability. , 2009, Current opinion in structural biology.

[21]  K. Kraemer,et al.  Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations , 2008, Journal of Medical Genetics.

[22]  M. S. Robaina-Castellanos,et al.  [Definition and classification of cerebral palsy: a problem that has already been solved?]. , 2007, Revista de neurología (Ed. impresa).

[23]  B. Dan,et al.  A report: the definition and classification of cerebral palsy April 2006 , 2007, Developmental medicine and child neurology. Supplement.

[24]  François Stricher,et al.  The FoldX web server: an online force field , 2005, Nucleic Acids Res..

[25]  P. Rosenbaum,et al.  The World Health Organization International Classification of Functioning, Disability, and Health: a model to guide clinical thinking, practice and research in the field of cerebral palsy. , 2004, Seminars in pediatric neurology.

[26]  Diana M Eccles,et al.  ACGS Best Practice Guidelines for Variant Classification 2019 , 2019 .

[27]  A. Maclennan,et al.  The emerging genetic landscape of cerebral palsy. , 2018, Handbook of clinical neurology.

[28]  Ann Johnson Prevalence and characteristics of children with cerebral palsy in Europe. , 2002, Developmental medicine and child neurology.

[29]  J W Mettau,et al.  Epidemiology of cerebral palsy. , 1993, Tropical and geographical medicine.